AI could predict strokes before they happen in heart patients
NCT ID NCT07441759
First seen Mar 04, 2026 · Last updated Jun 23, 2026 · Updated 10 times
Summary
This study will test whether an artificial intelligence (AI) tool can better predict stroke risk in 1,000 people aged 65-95 with atrial fibrillation, compared to current methods. The AI analyzes health records and heart data to identify high-risk individuals early. The goal is to prevent strokes and heart attacks by guiding earlier treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
EAP Tortose est. Servei d'Atencio Primaria i Comunitària. Institut Catala de la Salit
Tortosa, Tarragona, 43500, Spain
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-driven risk prediction model (MATHIAS strategy)
What this could lead to
If successful, this could lead to a more accurate way to predict stroke risk in people with atrial fibrillation, potentially preventing strokes and saving healthcare costs.
What could go wrong
This is a model-based evaluation, not a clinical trial testing a treatment. The AI tool may not work as well in real-world settings, and the study hasn't started recruiting yet.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.